Chondropathy
RecruitingStudy of BP CC 001 stem cells from umbilical cord tissue for treating knee cartilage damage
- Disease:Chondropathy
- Substances:–
Germany- Participants:18–64 years
- Sponsor:BIONCaRT GmbH
Rare diseases
Investigational molecules
Locations

Fuerstenweg 8, Seidewitz, 04668, Germany
BIONCaRT GmbH focuses on clinical research in cartilage defects of the knee joint, with interest in restoring damaged articular structures and addressing degenerative or traumatic knee cartilage injury.
The sponsor’s research activity is centered on therapies intended for local treatment of knee joint cartilage lesions.
BIONCaRT GmbH runs clinical trials in conditions such as Chondropathy, among others.
Clinical trials run by this sponsor – those enrolling participants first.
GermanyIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.